Medtronic (MDT)
81.93
+3.98 (5.11%)
NYSE· Last Trade: Jun 4th, 5:24 PM EDT
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerating organic growth. Read more.
Via Benzinga · June 4, 2026
Medtronic is on track to reverse after a major market meltdown driven by fear. The upside potential is double-digit, not including the dividend.
Via MarketBeat · June 4, 2026
Medtronic (MDT) Q4 2026 Earnings Transcript
Via The Motley Fool · June 4, 2026
Medtronic (NYSE:MDT) Posts In-Line Q4 Results, Fiscal 2026 Marks Highest Revenue Growth in a Decadechartmill.com
Via Chartmill · June 3, 2026
Medtronic (NYSE:MDT) Screens as a Top Dividend Stock with 3.63% Yield and Strong Fundamentalschartmill.com
Via Chartmill · May 26, 2026
Gapping S&P500 stocks in Thursday's sessionchartmill.com
Via Chartmill · June 4, 2026
These S&P500 stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · June 4, 2026
The most recent research report on the "Avascular Necrosis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts,
Via Talk Markets · June 4, 2026
Medtronic just wrapped up its best year in a decade.
Via The Motley Fool · June 3, 2026
Wednesday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · June 3, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · June 3, 2026
Medtronic has undergone a business revamp and is now ready to grow again, including by leaning into acquisitions.
Via The Motley Fool · June 3, 2026

Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardiovascular and diabetes tech.
Via Benzinga · June 3, 2026
Medtronic (NYSE:MDT) reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations.
Chairman and C
Via MarketBeat · June 3, 2026
Medtronic stock jumped Wednesday after the medical products giant said it requested new clearances in robotic surgery.
Via Investor's Business Daily · June 3, 2026

Medtronic to report Q4 2026 results with expected revenue of $9.61B and EPS of $1.55. Dividend yield is 3.83%.
Via Benzinga · June 3, 2026
Wondering what's happening in today's S&P500 pre-market session?chartmill.com
Via Chartmill · June 3, 2026

Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst ratings show mixed opinions.
Via Benzinga · June 3, 2026
High energy prices have investors worried about a recession; these businesses should survive the hit just fine.
Via The Motley Fool · May 30, 2026
The most recent research report on the "Hemodialysis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts, and p
Via Talk Markets · May 29, 2026
The most recent research report on the "Nitinol Medical Devices Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forec
Via Talk Markets · May 29, 2026
(BPT) - Key takeaways
Via Brandpoint · May 29, 2026
Top gainers and losers in the S&P500 index during Thursday's after-hours session.chartmill.com
Via Chartmill · May 28, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · May 28, 2026
The most recent research report on the "ENT Handheld Instruments Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic fore
Via Talk Markets · May 25, 2026